Zweig Di Menna Associates LLC Dexcom Inc Transaction History

Zweig Di Menna Associates LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 25, 2022	SELL	$94.08 - $130.2 $2.48 Million - $3.43 Million	-26,368 Closed	0 $0
Q4 2021 Jan 27, 2022	SELL	$129.87 - $162.82 $265,584 - $332,966	-2,045 Reduced 7.2%	26,368 $14.2 Million
Q3 2021 Oct 25, 2021	BUY	$106.71 - $143.18 $224,091 - $300,678	2,100 Added 7.98%	28,413 $15.5 Million
Q2 2021 Jul 29, 2021	BUY	$80.99 - $107.93 $2.13 Million - $2.84 Million	26,313 New	26,313 $11.2 Million
Q4 2020 Jan 26, 2021	SELL	$78.0 - $104.5 $3.74 Million - $5.01 Million	-47,934 Closed	0 $0

Q3 2020 Oct 27, 2020	BUY	$95.51 - $112.95 $755,770 - $893,773	7,913 Added 19.77%	47,934 $19.8 Million
Q2 2020 Jul 29, 2020	BUY	$62.68 - $105.34 $2.51 Million - $4.22 Million	40,021 New	40,021 $16.2 Million

1,123

353M

4.19M

4.54M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $43.5B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Zweig Di Menna Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Zweig Di Menna Associates LLC with notifications on news.